New non-oral drug delivery systems for Parkinson's disease treatment

By Md Shadab   Haque Shadabul   Sahni Jasjeet Kaur   Baboota Sanjula   Ali Javed  

Expert Opinion on Drug Delivery, Vol. 8, Iss. 3, 2011-03 ,pp. : 359-374

Informa Healthcare

Access to resources Recommend Favorite

Does diet protect against Parkinson's disease? Part 2 - Fat

By Brown Isabella Joanna  

Nutrition & Food Science, Vol. 34, Iss. 4, 2004-04 ,pp. : 147-150

Emerald Group Publishing Ltd

Access to resources Recommend Favorite

Insulin resistance syndrome: a potent culprit in cardiovascular disease

By Coulston A.M.   Peragallo-Dittko V.  

American Dietetic Association. Journal, Vol. 104, Iss. 2, 2004-02 ,pp. : 176-179

Elsevier

Access to resources Recommend Favorite

Interaction of Lipopolysaccharide Endotoxin Produced from Escherichia coli with D-Tubocurarine at the Nicotinic 2 Receptor and Adenosine 3':5' Cyclic Monophosphate during Physiological Contraction in Skeletal Muscle

By Seidenkrantz M.-S.   Bornmalm L.   Johnsen S.J.   Knudsen K.L.   Kuijpers A.   Lauritzen S.-E.   Leroy S.A.G.   Mergeai I.   Schweger C.   van Vliet-Lanoe B.   Finkler K.   Correa M.   Sultan S.A.R.   Elghribi N.M.   Tomera J.F.  

Food and Chemical Toxicology, Vol. 34, Iss. 1, 1996-01 ,pp. : 63-72

Elsevier

Access to resources Recommend Favorite

Advances in the delivery of treatments for Parkinson’s disease

By Johnston Tom H   Fox Susan H   Brotchie Jonathan M  

Expert Opinion on Drug Delivery, Vol. 2, Iss. 6, 2005-11 ,pp. : 1059-1073

Informa Healthcare

Access to resources Recommend Favorite